BioCentury
ARTICLE | Company News

Pellini joins Section 32

December 5, 2017 9:51 PM UTC

Section 32 named Michael Pellini managing partner. Pellini, who is chairman of cancer molecular profiling company Foundation Medicine Inc. (Cambridge, Mass.), will lead healthcare investments for the firm.

Section 32’s portfolio includes infectious disease companies Arsanis Inc. (NASDAQ:ASNS) and Vir Biotechnology Inc. (San Francisco, Calif.), cell therapy company Celularity Inc. (Warren, N.J.), and liquid biopsy company Freenome Inc. (South San Francisco, Calif.)...